science pharmaceutical expo biotech jobs

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitaichi, N.
Right arrow Articles by Taylor, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitaichi, N.
Right arrow Articles by Taylor, A. W.
(Journal of Leukocyte Biology. 2002;72:1117-1121.)
© 2002 by Society for Leukocyte Biology

Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells

Nobuyoshi Kitaichi*, Satoshi Kotake{dagger}, Taiki Morohashi{ddagger}, Kazunori Onoé{ddagger}, Shigeaki Ohno{dagger} and Andrew W. Taylor*

* Schepens Eye Research Institute and the Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and
{dagger} Department of Ophthalmology and Visual Sciences, Hokkaido University Graduate School of Medicine, and
{ddagger} Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan

Correspondence: Andrew W. Taylor, Ph.D., Schepens Eye Research Institute, 20 Staniford Street, Boston, MA 02114. E-mail: awtaylor{at}vision.eri.harvard.edu

To evaluate the potential role of NK1.1 (CD161c) cells in autoimmune uveoretinitis, we treated experimental autoimmune uveoretinitis (EAU)-susceptible mice with anti-CD161c antibodies (PK136) to deplete natural killer (NK) cells. Injection of anti-CD161c antibodies deleted NK cells from the peripheral blood of EAU-susceptible mice. The T cell proliferative response against the ocular autoantigen K2 was not suppressed in mice treated with anti-CD161c antibody when compared with T cells from control mice. Although mice treated with anti-CD161c developed EAU, the clinical severity on days 17 and 19 after induction of EAU was significantly mild in anti-CD161c-treated mice compared with control mice. In addition, the histopathological severity of EAU was significantly milder in mice treated with anti-CD161c antibodies than controls 21 days after induction of EAU. Our results indicate that the severity of EAU is augmented by NK1.1+ NK cells.

Key Words: NK1.1 • anti-CD161c • mouse




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
H. Kitamei, K. Iwabuchi, K. Namba, K. Yoshida, Y. Yanagawa, N. Kitaichi, M. Kitamura, S. Ohno, and K. Onoe
Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-{kappa}B (NF-{kappa}B), pyrrolidine dithiocarbamate
J. Leukoc. Biol., June 1, 2006; 79(6): 1193 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Y. Setiady, P. Pramoonjago, and K. S. K. Tung
Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex
J. Immunol., July 15, 2004; 173(2): 1051 - 1058.
[Abstract] [Full Text] [PDF]